Dupilumab Approved for Chronic Spontaneous Urticaria ...Middle East

Medscape - News
Dupilumab Approved for Chronic Spontaneous Urticaria
Resubmission of the supplemental biologics license application provided more data on improvement in hives and itching in patients ages 12 and older with CSU. Medscape Medical News

Read More Details
Finally We wish PressBee provided you with enough information of ( Dupilumab Approved for Chronic Spontaneous Urticaria )

Also on site :